NCT00828750 - Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic

Interventions

DRUG

Eltrombopag oral tablets

Eltrombopag oral tablets once daily

Trial Locations (6)

GSK Investigational Site, Gifu

GSK Investigational Site, Hiroshima

GSK Investigational Site, Ibaraki

GSK Investigational Site, Osaka

GSK Investigational Site, Osaka

GSK Investigational Site, Tokyo